Andreessen Horowitz (a16z) is showing less interest in digital health nowadays.
The prominent VC went from participating in 20 deals (worth $2.8B in total) in 2021 to just 10 deals (worth $341M) in 2022. In 2023 so far, the firm has only participated in 3 digital health deals (worth $120M).
Andreessen Horowitz’s reduced digital health investment reflects a more challenging funding environment for startups — with investors far less inclined to back mid- and late-stage deals at the sky-high valuations that were common during 2021’s funding boom.
Want the full post? Become a CB Insights customer.
If you’re already a customer, log in here.
The post Andreessen Horowitz is pulling back on digital health, but care delivery and wellness tech remain priorities appeared first on CB Insights Research.